✦ LIBER ✦

Primary biliary cirrhosis in elderly. Long-term treatment with ursodeoxycholic acid (UDCA)

✍ Scribed by R. Giner; O. Gonzalez; JJ Terradez; JV Ballester; M. Bixquert; R. Gil; J. Alegre; V. Cervera; J. Alonso

Book ID: 118881593
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 162 KB
Volume: 108
Category: Article
ISSN: 0016-5085
DOI: 10.1016/0016-5085(95)28588-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Methotrexate (MTX) plus ursodeoxycholic

Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis

✍ Burton Combes; Scott S. Emerson; Nancy L. Flye; Santiago J. Munoz; Velimir A. Lu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

This placebo-controlled, randomized, multicenter trial compared the effects of MTX plus UDCA to UDCA alone on the course of primary biliary cirrhosis (PBC). Two hundred and sixty five AMA positive patients without ascites, variceal bleeding, or encephalopathy; a serum bilirubin less than 3 mg/dL; se

Long-term ursodeoxycholic acid delays hi

Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis

✍ Paul Angulo; Kenneth P. Batts; Terry M. Therneau; Roberta A. Jorgensen; E. Rolla 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB 👁 1 views

Primary biliary cirrhosis (PBC) is a progressive cholestatic liver disease frequently leading to development of cirrhosis and its complications. Ursodeoxycholic acid (UDCA) is a beneficial medical therapy for patients with PBC. Improvement in some histological features, but not in histological stage

Long term ursodeoxycholic acid (URSO) tr

Long term ursodeoxycholic acid (URSO) treatment improves glutathione status in primary biliary cirrhosis (PBC)

✍ Philip Pemberton; Ali Aboutwerat; Alexander Smith; Sanjiv Jain; Ian Laing; Edwar 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Biochemical response to ursodeoxycholic

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

✍ Christophe Corpechot; Ludovico Abenavoli; Nabila Rabahi; Yves Chrétien; Tony And 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

Biochemical response to ursodeoxycholic acid (UDCA) in patients with primary biliary cirrhosis (PBC) is variable. It has been recently proposed that an alkaline phosphatase (ALP) decline of more than 40% in baseline value or a normal level after 1 year of UDCA treatment (Barcelona criteria) could se

Different response to ursodeoxycholic ac

Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease

✍ A. Floreani; F. Zappalà; M. Mazzetto; R. Naccarato; M. Plebani; M. Chiaramonte 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 698 KB

Bezafibrate in the treatment of primary

Bezafibrate in the treatment of primary biliary cirrhosis: comparison with ursodeoxycholic acid

✍ Takeshi Kurihara; Akiko Niimi; Atsushi Maeda; Mutsuo Shigemoto; Katsuko Yamashit 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 64 KB